Accessibility Menu
Sanofi logo

Sanofi(NASDAQ) SNY

Market Cap$108.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2002)+193%
5 Year+10%
1 Year-3%
1 Month+6%
Premium Feature
Moneyball Superscore
75/100
$45.99
+0.66%
+0.30Today
After hours$46.01+$0.02 (+0.04%)
Sanofi last closing stock price
MetricPriceDate
Last closeUSD 46.022026-08-25
Sanofi stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.33%USD 44.972026-08-18
1 month+6.16%USD 43.352026-07-24
3 month+3.58%USD 44.432026-05-27
Year to date+0.23%USD 45.922025-12-31
1 year-3.11%USD 47.502025-08-25
3 year-1.06%USD 46.512023-08-25
5 year+9.71%USD 41.952021-08-26
Since inception+193.22%USD 15.582002-07-01

Sanofi Financials at a Glance

Market Cap

$108.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€48.92B

Net Income (TTM)

€3.96B

EPS (TTM)

$1.94

P/E Ratio

23.43

Dividend

$2.42

Beta (Volatility)

0.33 (Low)

Price

$45.99

Volume

1,240,520

Open

$45.73

Previous Close

$46.02

Daily Range

$45.57 - $46.05

52-Week Range

$40.89 - $52.68

Estimated Earnings Date

Oct 23, 2026

SNY News

Getty - happy rich with cash money sitting

The Smartest Dividend Stock to Buy With $1,000 Right Now (Spoiler: It Yields 5.6%.)

Selena MaranjianJul 28, 2026
Investor pointing at a chart.

Bargain Hunters: These 3 High-Yielding Stocks Recently Hit New 52-Week Lows

David Jagielski, CPAJun 30, 2026
A team of scientists reviewing results in a lab.

1 Dirt Cheap Growth Stock to Buy Right Now

David Jagielski, CPAMay 18, 2026
bundle bills rolled and kept together with a rubber band sit on a table

What Is Price Elasticity of Demand?

Lee SamahaOct 13, 2025
GettyImages-1263079549.jpg

What Is Elasticity in Finance?

Motley Fool StaffApr 17, 2025
Child receiving a vaccination shot from a healthcare professional

Why Sanofi Stock Flew Higher on Friday

Eric VolkmanOct 25, 2024
Patient and physician smiling during a visit

Why Sanofi Stock Was Robustly Healthy Today

Eric VolkmanSep 3, 2024
GettyImages-487041745-drug

Sanofi's New Drug Could Help Deliver a Big Payday

Joseph WilbornMay 8, 2024
Page 1

SNY: Motley Fool Moneyball Superscore

75

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sanofi

Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare.

Products and Services
  • Specialized therapies for complex conditions, including oncology and rare diseases
  • Extensive vaccine portfolio for pediatric and adult immunizations
  • Over-the-counter products for wellness, pain management, and personal care
Growth Outlook
  • Strong revenue growth with Q2 2026 revenue of €12.3 billion
  • Continued investment in R&D, with €2.2 billion allocated in Q2 2026
  • Strategic partnerships enhancing product pipeline and market reach
Financial Highlights
  • Net income of €343 million in Q2 2026, reflecting operational efficiency
  • TTM revenue of €48.5 billion, showcasing consistent demand for products
  • Dividend yield of 5.37%, indicating strong shareholder returns
Sanofi's diverse product offerings and strategic focus on innovation position the company well for future growth. The recent quarterly performance highlights a robust revenue stream and effective cost management, contributing to a solid net income. The commitment to research and development underscores the company's dedication to advancing healthcare solutions. With a strong dividend yield, Sanofi also demonstrates its commitment to returning value to shareholders. Overall, the company's strategic initiatives and financial health make it an attractive option for potential investors.
AI Generated • Aug 18, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

76,493

CEO

Paul Hudson

Website

www.sanofi.com

Headquarters

Paris, IF 75017, FR

SNY Financials

Key Financial Metrics (TTM)

Gross Margin

72.77%

Operating Margin

20.58%

Net Income Margin

8.09%

Return on Equity

5.52%

Return on Capital

10.47%

Return on Assets

3.07%

Earnings Yield

4.27%

Dividend Yield

5.29%

Payout Ratio

1.24%

Stock Overview

Market Cap

$108.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.38B

Volume

1.24M

Avg. Volume

3.36M

Financials (TTM)

Gross Profit

€35.72B

Operating Income

€7.24B

EBITDA

€12.41B

Operating Cash Flow

€14.29B

Capital Expenditure

-€2.52B

Free Cash Flow

€11.77B

Cash & ST Invst.

€6.35B

Total Debt

€23.58B

Sanofi Performance Analysis

Sanofi annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 45,188,742,6911.2%
20232023-12-31EUR 40,884,548,758-9.5%
20242024-12-31EUR 44,436,937,9608.7%
20252025-12-31EUR 49,235,341,67210.8%
Sanofi sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3022.7%
Q42025-12-31-7.3%
Q12026-03-31-7.9%
Q22026-06-309.4%
Sanofi annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 3.5019.7%
20232023-12-31EUR 2.32-33.6%
20242024-12-31EUR 2.393.0%
20252025-12-31EUR 2.400.1%
Sanofi sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-28.8%
Q42025-12-31-229.1%
Q12026-03-31145.7%
Q22026-06-30-79.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€12.30B

+14.6%

Gross Profit

€9.28B

+19.9%

Gross Margin

75.47%

N/A

Market Cap

$108.90BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.42M

N/A

Employees

76,493

N/A

Net Income

€343.00M

-91.3%

EBITDA

€1.68B

-11.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€6.35B

-58.7%

Total Debt

€23.58B

+5.8%

Accounts Receivable

€9.21B

+12.2%

Inventory

€24.12B

+150.8%

Long Term Debt

€16.32B

+10.9%

Short Term Debt

€7.25B

-4.1%

Return on Assets

3.07%

N/A

Return on Invested Capital

10.37%

N/A

Free Cash Flow

€3.90B

N/A

Operating Cash Flow

€5.42B

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSKGSK plc
$52.07+0.56%
MDTMedtronic plc
$91.14-1.89%
CVSCVS Health Corp.
$92.90-1.29%
HCAHCA Healthcare, Inc.
$428.76-0.11%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$213.05+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.09+0.01%
INTCIntel
$87.48+0.00%
BITOProShares Trust - ProShares Bitcoin ETF
$10.66+0.00%

Questions About SNY

What is the current price of Sanofi?

Sanofi is trading at $46.02 per share.

What is the 52-week range for Sanofi?

Over the past 52 weeks, Sanofi has traded between $40.89 and $52.68.

How much debt does Sanofi have?

As of the most recent reporting period, Sanofi reported total debt of €23.88B.

How much cash does Sanofi have on hand?

Sanofi reported €8.68B in cash and cash equivalents in its most recent financial results.

What is Sanofi’s dividend yield?

Sanofi currently has a dividend yield of 5.29%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services